Germline BRCA1 mutations confer a significant lifetime susceptibility to breast and ovarian cancer, with reported absolute risks of 45% to 87% for breast cancer and 36% to 66% for ovarian cancer by age 70 [1,10]. This evidence concerns the gene BRCA1 and ovarian carcinoma.